Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05250427
Other study ID # DAS-006
Secondary ID U1111-1266-5484
Status Completed
Phase
First received
Last updated
Start date April 26, 2022
Est. completion date May 23, 2022

Study information

Verified date June 2022
Source Novo Nordisk A/S
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

ACTION APAC is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor through existing databases/panels in APAC region. The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.


Recruitment information / eligibility

Status Completed
Enrollment 12404
Est. completion date May 23, 2022
Est. primary completion date May 23, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: People Living with Obesity 1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol). 2. Male or female, aged above or equal to 18 years at the time of signing informed consent 3. Lives in one of the target countries 4. Current BMI of at least 25 kg/m^2 for all countries (except Singapore which has current BMI 27 kg/m^2) based on self-reported height and weight Health Care Professionals 1. Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol) 2. Male or female, aged greater than or equal to 18 years at the time of signing informed consent. 3. Physician 4. Primary Care Providers (PCPs) whose specialty is Family practice, General practice, Internal Medicine 5. Non-PCP Specialties whose specialty is Endocrinologist, Cardiologist, Gastroenterologist, Obstetrics/Gynaecologist, Bariatrics/Obesity Medicine, Nutrition Specialist (physician) Orthopaedist, Aesthetics Medicine 6. Specialty is not surgeon (including bariatric or plastic surgeon) 7. Practices in the target countries 8. In clinical practice for at least 2 years 9. Spends at least 50% time in direct patient care 10. Has seen at least 100 patients in past month 11. Has seen at least 10 patients in past month who have obesity defined as: a patient with a BMI greater than or equal to 25 kg/m^2 for all countries (except Singapore which has current greater than or equal to BMI 27 kg/m^2) with or without comorbidities. Exclusion criteria: People Living with obesity 1. Previous participation in this study. Participation is defined as having given online consent in this study 2. Currently pregnant 3. Participates in intense fitness or body building programs 4. Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months 5. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation Health Care Providers 1. Previous participation in this study. Participation is defined as having given informed consent in this study. 2. Unwillingness, inability, or language barriers precluding adequate understanding or cooperation

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No treatment given
No treatment given

Locations

Country Name City State
Bangladesh Novo Nordisk Investigational Site Dhaka
India Novo Nordisk Investigational Site Bangalore
Indonesia Novo Nordisk Investigational Site Jakarta
Malaysia Novo Nordisk Investigational Site Kuala Lumpur
Pakistan Novo Nordisk Investigational Site Karachi
Philippines Novo Nordisk Investigational Site Manila
Singapore Novo Nordisk Investigational Site Singapore
Thailand Novo Nordisk Investigational Site Bangkok
Vietnam Novo Nordisk Investigational Site Ho Chi Minh

Sponsors (1)

Lead Sponsor Collaborator
Novo Nordisk A/S

Countries where clinical trial is conducted

Bangladesh,  India,  Indonesia,  Malaysia,  Pakistan,  Philippines,  Singapore,  Thailand,  Vietnam, 

Outcome

Type Measure Description Time frame Safety issue
Primary Weight loss motivators for improving health of PLwO Multi-select from defined list At the time of survey response (Day 1)
Primary Weight loss barriers for improving health of PLwO Multi-select from defined list At the time of survey response (Day 1)
Primary Weight loss management for improving health of PLwO Multi-select from defined list At the time of survey response (Day 1)
Primary Weight loss responsibility for improving health of PLwO Multi-select from defined list At the time of survey response (Day 1)
Primary Proportion of PLwO who made serious weight loss effort Number of weight loss efforts; percentage of patients At the time of survey response (Day 1)
Primary Response to weight loss discussions Single select from defined list At the time of survey response (Day 1)
Primary Attitudes towards obesity and weight management and Interactions of PLwOs with HCPs 5-point Likert scales At the time of survey response (Day 1)
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2